Hydrocodone/homatropine
Jump to navigation
Jump to search
| Combination of | |
|---|---|
| Hydrocodone | Opioid agonist |
| Homatropine | Muscarinic antagonist |
| Clinical data | |
| Trade names | Tussigon, Hycodan, Hydromet, others |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| License data | |
| Routes of administration | By mouth |
| ATC code |
|
| Legal status | |
| Legal status | |
| Identifiers | |
| CAS Number | |
| KEGG | |
| E number | {{#property:P628}} |
| CompTox Dashboard (EPA) |
|
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value). |
Hydrocodone/homatropine, sold under the brand name Tussigon among others, is a fixed-dose combination medication used for the treatment of cough.[1][2] It contains hydrocodone, as the bitartrate, an opioid agonist; and homatropine, as the methylbromide, a muscarinic antagonist.[1][2] It is taken by mouth.[1][2]
Hydrocodone/homatropine was approved for medical use in the United States in 1943.[1][2]
Adverse effects
[edit | edit source]In the US, the label for hydrocodone/homatropine contains a black box warning about addiction, abuse, and misuse.[1][2]
References
[edit | edit source]Lua error in mw.title.lua at line 392: bad argument #2 to 'title.new' (unrecognized namespace name 'Portal'). Lua error in Module:Authority_control at line 153: attempt to index field 'wikibase' (a nil value).
